Sr One Capital Management as of June 30, 2024
Portfolio Holdings for Sr One Capital Management
Sr One Capital Management holds 9 positions in its portfolio as reported in the June 2024 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Arcellx Common Stock (ACLX) | 40.5 | $130M | 2.3M | 55.19 | |
| CRISPR Therapeutics Common Shares (CRSP) | 17.7 | $57M | 1.0M | 54.01 | |
| ARS Pharmaceuticals Common Stock (SPRY) | 10.7 | $34M | 4.0M | 8.51 | |
| Alumis Common Stock (ALMS) | 8.2 | $26M | 2.0M | 13.30 | |
| Mineralys Therapeutics Common Stock (MLYS) | 7.4 | $24M | 2.0M | 11.70 | |
| Design Therapeutics Common Stock (DSGN) | 6.8 | $22M | 6.5M | 3.35 | |
| Nkarta Common Stock (NKTX) | 6.2 | $20M | 3.3M | 5.91 | |
| enGene Holdings Common Shares (ENGN) | 1.5 | $4.7M | 500k | 9.43 | |
| KALA Bio Common Stock (KALA) | 1.0 | $3.1M | 444k | 7.09 |
